Strengthening the clinical research in long-term therapy of hepatitis B: beginning with the end in mind
10.3760/cma.j.issn.1007-3418.2017.07.001
- VernacularTitle: 加强乙型肝炎长期治疗临床研究：以终为始
- Author:
Xueru YIN
1
;
Yuecheng YU
2
;
Jinlin HOU
1
Author Information
1. Institute of Hepatology, Southern Medical University, Guangzhou 510515, China
2. Liver Disease Center of PLA, Bayi Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China
- Publication Type:Editorial
- Keywords:
Hepatitis B;
Therapy;
Therapies, investigational;
Clinical outcome
- From:
Chinese Journal of Hepatology
2017;25(7):481-484
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B is a serious public health issue in China. The clinical management of hepatitis B is effective with the emergence of antiviral agents. The outcome of long-term therapy and nucleos(t)ide analogues stopping rules are currently unresolved issues and unmet needs. Thus, we need to pay more attention to clinical research to build large-sample and long-term follow-up cohorts and begin with the end in mind. We believe that the way to resolve the issues above will be found with the efforts of generations.
